Streetbeat News

CURLF

Curaleaf Holdings Inc

Employees

5,138

Industry

Medicinal and Botanical Manufacturing

Open

2.30

Mkt cap

1.6B

Volume

197K

High

2.30

P/E Ratio

-7.03

52-wk high

6.40

Low

2.08

Div yield

N/A

52-wk low

2.07

Germany's cannabis legalization has entered its first phase, allowing adults over 18 to possess and cultivate marijuana under specific limits. Lawmakers are pushing for the second phase, which involves state-controlled sales in licensed shops. Curaleaf, a major cannabis producer, is considering a secondary listing in Europe, eyeing Frankfurt and London, following its expansion in Germany through the acquisition of Northern Green Canada. Curaleaf shares closed 7.49% higher at $5.60.

Portfolio Pulse from Nina Zdinjak

April 08, 2024 | 1:41 pm

Cannabis stocks experienced significant movements on April 4, 2024, with notable gainers including Choom Holdings, Target Group, and Heritage Cannabis Holding. Conversely, CNBX Pharmaceuticals and Global Compliance led the losers. The volatility reflects ongoing market adjustments within the cannabis sector.

Portfolio Pulse from Benzinga Insights

April 04, 2024 | 8:30 pm

Following a Florida Supreme Court decision, a report by Pablo Zuanic predicts a 400% growth in Florida's cannabis market if legalization passes in Nov. 2024, potentially increasing the market to $6B. Companies like Cansortium, AYR Wellness, iAnthus, SNDL, Trulieve, Planet 13, Cannabist, Cresco, Verano, and Curaleaf are expected to see significant valuation increases. The report also anticipates increased M&A activity and benefits for ancillary service providers like WM Technology.

Portfolio Pulse from Nicolás Jose Rodriguez

April 03, 2024 | 8:36 pm

Following the Florida Supreme Court's decision to allow a constitutional amendment for legalizing recreational marijuana on the November 2024 ballot, cannabis companies, including Trulieve, have collectively contributed over $15 million in support. Trulieve had previously donated $40 million. The amendment, known as Amendment 3, aims to legalize non-medical personal use of marijuana for adults 21 or older and requires a 60% voter approval. Companies like Verano Holdings, Curaleaf Holdings, AYR Wellness, Cresco Labs, Green Thumb Industries, and INSA, Inc. are among the new donors. The funding announcement coincides with the upcoming Benzinga Cannabis Capital Conference in Florida.

Portfolio Pulse from Maureen Meehan

April 03, 2024 | 7:56 pm

AYR Wellness Inc. (OTC:AYRWF) launched its Kynd brand's premium edibles in Florida and Nevada, targeting the $2.2 billion edibles market with vegan gluten-free options. The company reported a 10% revenue increase in 2023 to $463.6 million, despite a widened net loss. The Florida cannabis market, where AYR Wellness is expanding, is valued at over $1.4 billion with a 30% growth rate. Nevada's market, also targeted by AYR, is valued at $850 million, benefiting from tourist traffic and strong economics. Other companies mentioned include Trulieve (OTC:TCNNF), Green Thumb Industries (OTC:GTBIF), Curaleaf Holdings (OTC:CURLF), Jushi Holdings (OTC:JUSHF), and Planet 13 Holdings (OTC:PLNHF).

Portfolio Pulse from Nicolás Jose Rodriguez

March 30, 2024 | 2:54 pm

The article reports significant movements in cannabis stocks on March 28, 2024, listing both gainers and losers. Encompass Health (EHC) and Eastside Distilling (EAST) were among the gainers, while Urban-gro (UGRO), 22nd Century Group (XXII), Canopy Growth (CGC), Aurora Cannabis (ACB), GrowGeneration (GRWG), SNDL Inc. (SNDL), OrganiGram Holdings (OGI), and Village Farms International (VFF) were notable losers.

Portfolio Pulse from Benzinga Insights

March 28, 2024 | 8:30 pm

The article lists cannabis stock gainers and losers for March 27, 2024, highlighting significant movements in the sector. Notable gainers include Canopy Growth, Maple Leaf Green World, and Cara Therapeutics, with increases of 30.57%, 23.64%, and 19.15% respectively. On the losing end, Green Growth Brands plummeted by 99%, followed by CordovaCann and Item 9 Labs with substantial declines. The article reflects the volatile nature of the cannabis market.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 8:30 pm

The upcoming Benzinga Cannabis Capital Conference will feature discussions on scaling marijuana businesses to self-sustainability, with insights from industry experts Seth Yakatan, Bryan Gerber, and Jon Levine. Yakatan emphasizes operating within market constraints due to federal illegality and capital challenges. Gerber's Hara Supply, a major player in the cone industry, serves clients like Verano Holdings and Curaleaf, boasting significant market share and profitability. Levine, of MariMed, highlights the importance of consistency and passion in achieving success in the cannabis industry. The conference aims to provide strategies for growth amidst regulatory and financial hurdles.

Portfolio Pulse from Nina Zdinjak

March 27, 2024 | 6:30 pm

New York Governor Kathy Hochul has ordered a comprehensive review of the state's cannabis licensing process to address inefficiencies and the proliferation of illicit pot shops. The review, led by Jeanette Moy, aims to expedite the application process and improve the Office of Cannabis Management (OCM). The OCM, criticized for its slow rollout and legal challenges, has processed only a fraction of the applications received. The situation has led to multiple lawsuits from entities including Acreage Holdings, Curaleaf Holdings, Green Thumb Industries, and PharmaCann, highlighting issues with the social equity program and application procedures.

Portfolio Pulse from Nina Zdinjak

March 18, 2024 | 11:25 am

Cannabis stocks surged following a tweet by hedge fund manager Doug Kass, suggesting the DEA will soon reschedule cannabis to Schedule III, potentially easing business burdens for the industry. Stocks like Curaleaf Holdings, Canopy Growth, and others saw significant gains. The upcoming Benzinga Cannabis Capital Conference will further discuss these developments.

Portfolio Pulse from Maureen Meehan

March 15, 2024 | 5:28 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.